ADIL Q2 EPS Increased by Brookline Capital Management
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Stock analysts at Brookline Capital Management increased their Q2 2025 earnings per share estimates for Adial Pharmaceuticals in a research report issued to clients and investors on Thursday, May 15th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Stock analysts at Brookline Capital Management increased their Q2 2025 earnings per share estimates for Adial Pharmaceuticals in a research report issued to clients and investors on Thursday, May 15th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of […]
